These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2004-004348-39 Effect of Strict Control of Blood Sugar with Insulin Regimen on Prevention of Atrial Fibrillation after Coronary Artery Bypass Grafting. 2008-07-04 due-trials
Reported results 2006-005715-10 The Control of Hyperglycaemia In Paediatric intensive care (The CHIP Trial). 2011-09-30 due-trials
Not reported 2007-001643-21 Use of endothelin-1 antagonists in patients with Established Pulmonary Hypertension and Fibrotic Lung Disease. 2012-07-01 due-trials
Reported results 2007-001645-17 Prevention of Established Pulmonary Hypertension in High Risk patients with Fibrotic Lung Disease – a double-blinded, randomised, placebo controlled trial with endothelin-1 receptor antagonist therap... 2007-11-28 due-trials
Not reported Terminated 2007-002652-42 The use of clopidogrel and aprotonin in off pump coronary artery bypass grafting 2007-11-15 due-trials
Not reported Terminated 2007-007877-22 A prospective blinded randomised placebo controlled trial investigating whether oxycodone modified release reduces parenteral opioid use following intermediate thoracic surgery 2011-12-13 due-trials
Reported results 2010-019302-16 A prospective, randomised, placebo-controlled, double blind, multi-centre study of the effects of Irbesartan on aortic dilatation in Marfan syndrome 2018-03-12 due-trials
Reported results 2010-020219-35 Evaluating the benefit of additional platelet inhibition in acute coronary syndrome patients with high platelet reactivity undergoing PCI 2013-10-17 due-trials
Ongoing 2012-003633-42 A randomized, double blind controlled trial comparing rituximab against intravenous cyclophosphamide in connective tissue disease associated interstitial lung disease not-yet-due
Ongoing 2013-002094-22 Comparison of ultra-low-dose Oral versus Transdermal Hormone Therapy on coagulation activation and metabolic risk factors for Cardiovascular Disease not-yet-due
Reported results 2013-004355-20 Randomised, controlled crossover trial to evaluate the Effects of Ambulatory Oxygen on health status in patients with Fibrotic Lung Disease (FLD) 2017-01-13 due-trials
Not reported Terminated 2014-000091-25 A single-centre, placebo-controlled, double-blinded, randomized, cross-over study of Iloprost (Ventavis®) in patients with Eisenmenger syndrome 2018-04-30 due-trials
Not reported Terminated 2014-000182-45 A pilot study into health pre and post treatment with intravenous Aminophylline and Hydrocortisone in severe asthmatics 2015-02-26 due-trials
Ongoing 2015-005351-27 A randomised controlled pilot trial of the feasibility and safety of therapy withdrawal in asymptomatic patients with a prior diagnosis of dilated cardiomyopathy & recovered cardiac function. not-yet-due
Ongoing 2016-000829-39 Iron and Chronic Obstructive Pulmonary Disease (COPD) Exercise Trial not-yet-due
Ongoing 2017-003665-10 A single-centre study of the relationship between eosinophil activation and the lung microbiome in severe eosinophilic asthma (SEA) and the effect of benralizumab on these factors not-yet-due
Ongoing 2019-003571-19 PAciFy Cough: A multicentre, double blind, placebo controlled, crossover trial of morphine sulfate for the treatment of PulmonAry Fibrosis Cough not-yet-due